Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion‐dependent β‐thalassemia

2024-9-12

Cybersecurity and the blood supply: The vulnerabilities of the technological revolution

2024-9-12

Machine‐learning based subgroups of <scp>AL</scp> amyloidosis and cumulative incidence of mortality and end stage kidney disease

2024-9-11

Quadruplets in newly diagnosed transplant‐ineligible multiple myeloma

2024-9-10

Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A multi‐institutional study

2024-9-10

Haploidentical hematopoietic cell transplantation as a platform for natural killer cell immunotherapy

2024-9-9

Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management

2024-9-6

Issue Information

2024-9-5

Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

2024-8-31

Long‐term outcomes of renal <scp>AL</scp> amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system

2024-8-29

Posttraumatic stress disorder increases thrombosis risk: Evidence from a biobank data set

2024-8-29

Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐<scp>BCMA CAR</scp> T‐cell‐based therapy

2024-8-28

Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon

2024-8-28

A phase 2 trial of mini‐hyper‐<scp>CVD</scp>, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia

2024-8-28

Presentation of chronic myeloid leukemia in basophilic blast crisis

2024-8-23

Successful 13‐year ongoing remission with <scp>C5</scp> inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome

2024-8-23

Comparative clinical efficacy and safety of biosimilar <scp>ABP</scp> 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria

2024-8-22

Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (<scp>WBMT</scp>)

2024-8-19

Serum iron and transferrin saturation variation are circadian regulated and linked to the harmonic circadian oscillations of erythropoiesis and hepatic <scp><i>Tfrc</i></scp> expression in mice

2024-8-17

Intra‐tumoral and peripheral blood <scp>TIGIT</scp> and <scp>PD</scp>‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma

2024-8-17

Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia

2024-8-17

Imatinib versus newer generation <scp>TKIs</scp> for upfront therapy in chronic phase <scp>chronic myeloid leukemia</scp>: What is the rationale for paying more to get the same survival benefit?

2024-8-14

The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes

2024-8-13

Exercise and training in sickle cell disease: Safety, potential benefits, and recommendations

2024-8-12

Self‐pay laboratory charges for iron deficiency diagnosis in the Boston and New Haven metropolitan areas

2024-8-9

Are veterans at increased risk of myeloproliferative neoplasms?

2024-8-9

Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma

2024-8-7

Long‐term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A <scp>STELLAR</scp> interim analysis

2024-8-6

2025 update on clinical trials in immune thrombocytopenia

2024-8-6

Ferritin reference intervals in a population of working‐age adults without anemia

2024-8-5

Issue Information

2024-8-4

Timing and outcomes of second‐line therapy in the era of daratumumab‐based frontline therapy in AL amyloidosis

2024-8-3

Optimal frontline therapy of chronic myeloid leukemia today, and related musings

2024-8-2

Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring

2024-8-2

Echinocytes in pyruvate kinase deficiency, post‐splenectomy

2024-8-2

Where hematology meets rheumatology—<scp>VEXAS</scp> syndrome

2024-7-30

Isolated peripheral nervous system relapse after allogeneic hematopoietic cell transplantation for T‐cell acute lymphoblastic leukemia

2024-7-30

Mitapivat for phosphofructokinase deficiency

2024-7-23

Advances in sickle cell retinopathy screening techniques, tests, and practices: A systematic review

2024-7-23

Network meta‐analysis of upfront fixed‐duration therapies in chronic lymphocytic leukemia

2024-7-23

Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin <scp>H</scp> disease

2024-7-22

A growing panoply of options for patients with paroxysmal nocturnal hemoglobinuria

2024-7-18

Risk of myeloproliferative neoplasms among <scp>U.S.</scp> Veterans from Korean, Vietnam, and Persian Gulf War eras

2024-7-18

Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia

2024-7-17

Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?

2024-7-17

Correction to “Risk factors for severe infection and mortality in patients with <scp>COVID</scp>‐19 in patients with multiple myeloma and <scp>AL</scp> amyloidosis”

2024-7-12

Correction to “Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma”

2024-7-12